Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT06559163

Public ClinicalTrials.gov record NCT06559163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obexelimab in Patients With Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT06559163
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zenas BioPharma (USA), LLC
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2024 (Actual)
Primary completion
Sep 2026 (Estimated)
Completion
Dec 2026 (Estimated)
Last update posted
Aug 18, 2026

2024 – 2026

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Onyx Clinical Research Peoria Arizona 85381 —
Sierra Pacific Arthritis and Rheumatology Centers Fresno California 93710 —
California Research Institute Huntington Park California 90255 —
University of California, San Diego La Jolla California 92037 —
University of California, Los Angeles Los Angeles California 90024 —
Solace Clinical Research Tustin California 92780 —
Yale University New Haven Connecticut 06520 —
Clinical Research of West Florida, Inc Clearwater Florida 33765 —
Clinical Research of West Florida, Inc. Tampa Florida 33606 —
Emory University Atlanta Georgia 30322 —
AARA Clinical Research - Chicago Arthritis & Regenerative Medicine Chicago Illinois 60661 —
Orthoillinois Rockford Illinois 61114 —
Willow Rheumatology and Wellness Willowbrook Illinois 60527 —
Accurate Clinical Research Lake Charles Louisiana 70605 —
Axon Clinical Research Baltimore Maryland 21237 —
UMass Chan Medical School Worcester Massachusetts 01655 —
Henry Ford Hospital Detroit Michigan 48202 —
Juno DO, PC Lansing Michigan 48911 —
Revive Research Institute - Sterling Heights Sterling Heights Michigan 48313 —
Velocity Clinical Research St Louis Missouri 63131 —
Hospital for Special Surgery New York New York 10021 —
SUNY Upstate Medical University Syracuse New York 13210 —
DJL Clinical Research PLLC Charlotte North Carolina 28211 —
Cross Creek Medical Clinic Fayetteville North Carolina 28304 —
Onsite Clinical Solutions Salisbury North Carolina 28144 —
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104-5005 —
Penn State - Hershey Medical Center Hershey Pennsylvania 17033 —
AARA Clinical Research - Rheumatology Specialty Center Willow Grove Pennsylvania 19090 —
Prolato Clinical Research Center (PCRC) Houston Texas 77054 —
Accurate Clinical Research Houston Texas 77089 —
Prime Clinical Research - Lewisville Lewisville Texas 75067 —
Prime Clinical Research - Mansfield Mansfield Texas 76063 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06559163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06559163 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →